![Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/09/ced-pexels-13091435.jpg?resize=150%2C150&ssl=1 "Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z] 8")
Using Cannabis to Cut Back on Alcohol? Your Working Memory Might Dictate If It Works
Cannabis substitution alcohol use disorder effectiveness varies by working memory capacity. Patients with intact working memory may reduce alcohol cravings using cannabis. This highlights the need for personalized treatment strategies.
Daily Digest: Cannabis Impact on Adolescent Brain in 2026
2026 cannabis adolescent brain vulnerability is a growing concern among researchers. Studies link teen cannabis use to increased psychiatric risks such as psychosis and depression. Understanding these risks is critical for public health and clinical…
Daily Digest: Last 24 Hours: Brain Aging, Driving Safety, and the Global Fight for Patient Access — March 05, 2026
Recent studies on cannabis cognitive aging older adults provide reassuring data about cognitive decline risks. Evidence shows THC blood levels poorly predict driving impairment. Patient access remains a critical issue in the U.S. and U.K. healthcare…
The Wait is Over: Medical Cannabis Set to Roll Out in Alabama in April
Alabama medical cannabis program is moving forward with an official rollout planned for April. This program will expand patient access to cannabis therapeutics under state regulations. Physicians should prepare to integrate Alabama medical cannabis…
GLP-1 Medications Get at the Heart of Addiction, Study Finds
GLP-1 medications addiction treatment shows promise in reducing cannabis use disorder alongside other substance use disorders. These medications may address multiple addiction pathways simultaneously rather than targeting individual substances.…
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
NHS access barriers medical cannabis remain a critical issue for pediatric drug-resistant epilepsy patients in the UK. Despite legal changes, many children cannot access cannabinoid therapies through the NHS. This campaign highlights the urgent need for…
Daily Digest: Cannabis Impairment Testing, Brain Aging, and Evidence Race — March 05, 2026
The 2026 cannabis brain aging study highlights important neurobiological effects of regular cannabis use. This research provides critical insights into impairment testing challenges and clinical counseling. Clinicians should consider these findings when…
Pres. Trump’s Executive Mandate Speeds DEA Licensing for Cannabis Research
DEA licensing cannabis research is accelerating due to recent executive actions. This change addresses longstanding regulatory delays that have hindered clinical investigation. The streamlined approval process is expected to expand research on cannabis…
Omagh Biotech Start-Up Boosts Research into Obesity and Epilepsy
Sonas Pharma’s funding boost advances endocannabinoid system obesity epilepsy research. This biotech aims to develop targeted therapeutics for these challenging conditions. The focus on endocannabinoid system obesity epilepsy offers hope for improved…
What to Know About How GLP-1 Medications Might Fight Addiction – The Washington Post
GLP-1 receptor agonist addiction treatment shows promise as a novel approach for substance use disorders. These medications, already used for metabolic diseases, may reduce cravings by affecting brain reward pathways. Ongoing research is crucial to…